High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours
Veterinary and Comparative Oncology · 2023
DOI: 10.1111/vco.12898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2023. Verfasst von Julia Antongiovanni Joselevitch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Oncologia Comparada e Translacional, Faculdade de Zootecnia e Engenharia de Alimentos, Universidade de São Paulo, Pirassununga, Brazil. Hauptthemen laut MEDLINE: Dog Diseases, Mastocytoma, Skin, Skin Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Mast cell tumour (MCT) is one of the most frequent skin tumours in dogs. Due to their unpredictable biological behaviour, MCTs often cause several therapeutic frustrations, leading to investigation regarding prognostic markers. Lysyl oxidase (LOX) is an enzyme that promotes extracellular matrix stability and contributes to cell migration, angiogenesis and epithelial‐mesenchymal transition. Its expression positively correlates with poor prognoses in several human and canine mammary cancers. The aim of this study was to characterise the immunohistochemical expression of LOX in MCT samples and compare it with histological grading and post‐surgical survival. Twenty‐six tumours were submitted to immunohistochemistry for LOX expression evaluation. All samples were positive for LOX, with variable percentages of cytoplasmic and nuclear positivity. Cytoplasmic positivity was significantly higher in high‐grade MCTs ( P = .0297). Our results indicate that high expression of cytoplasmic LOX in neoplastic mast cells is an indicator of poor prognosis for canine cutaneous MCTs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Oncologia Comparada e Translacional, Faculdade de Zootecnia e Engenharia de Alimentos, Universidade de São Paulo, Pirassununga, Brazil.
- Faculdade de Medicina Veterinária e Zootecnia, Departamento de Patologia, Universidade de São Paulo, São Paulo, Brazil.
- Clínica E+ Especialidades, São Paulo, Brazil.
- Universidade Anhembi Morumbi, São Paulo, Brazil.
- Universidade Metodista de São Paulo, São Bernardo do Campo, Brazil.
- Universidade Paulista, São Paulo, Brazil.
ORCID-Profile: Julia Antongiovanni Joselevitch, Ricardo De Francisco Strefezzi
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Joselevitch, J. A., Vargas, T. H. M., Pulz, L. H., Cadrobbi, K. G., Huete, G. C., Nishiya, A. T., Kleeb, S. R., Xavier, J. G., & Strefezzi, R. F. (2023). High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.12898
Vancouver
Joselevitch JA, Vargas THM, Pulz LH, Cadrobbi KG, Huete GC, Nishiya AT, et al. High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours. Veterinary and Comparative Oncology. 2023. doi:10.1111/vco.12898
BibTeX
@article{Joselevitch2023,
author = {Joselevitch, Julia Antongiovanni and Vargas, Thiago Henrique Moroni and Pulz, Lidia Hildebrand and Cadrobbi, Karine Germano and Huete, Greice Cestari and Nishiya, Adriana Tomoko and Kleeb, Silvia Regina and Xavier, José Guilherme and Strefezzi, Ricardo De Francisco},
title = {High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours},
journal = {Veterinary and Comparative Oncology},
year = {2023},
doi = {10.1111/vco.12898}
}
EUVIMED